167 related articles for article (PubMed ID: 15221157)
1. Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study.
Carvajal A; Arias LH; Vega E; Sánchez JA; Rodríguez IM; Ortega PG; del Pozo JG
Eur J Clin Pharmacol; 2004 Aug; 60(6):439-44. PubMed ID: 15221157
[TBL] [Abstract][Full Text] [Related]
2. Underutilization of preventive strategies in patients receiving NSAIDs.
Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
[TBL] [Abstract][Full Text] [Related]
3. Co-prescription of gastroprotective agents and their efficacy in elderly patients taking nonsteroidal anti-inflammatory drugs: a systematic review of observational studies.
Medlock S; Eslami S; Askari M; Taherzadeh Z; Opondo D; de Rooij SE; Abu-Hanna A
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1259-1269.e10. PubMed ID: 23792548
[TBL] [Abstract][Full Text] [Related]
4. The use of prophylactic gastroprotective therapy in patients with nonsteroidal anti-inflammatory drug- and aspirin-associated ulcer bleeding: a cross-sectional study.
Ho CW; Tse YK; Wu B; Mulder CJ; Chan FK
Aliment Pharmacol Ther; 2013 Apr; 37(8):819-24. PubMed ID: 23432193
[TBL] [Abstract][Full Text] [Related]
5. Prescription of nonsteroidal anti-inflammatory drugs and co-prescribed drugs for mucosal protection: analysis of the present status based on questionnaires obtained from orthopedists in Japan.
Tsumura H; Tamura I; Tanaka H; Chinzei R; Ishida T; Masuda A; Shiomi H; Morita Y; Yoshida M; Kutsumi H; Inokuchi H; Doita M; Kurosaka M; Azuma T
Intern Med; 2007; 46(13):927-31. PubMed ID: 17603228
[TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
7. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
Yeomans ND
Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
[TBL] [Abstract][Full Text] [Related]
8. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study].
Lanas A; Muñoz M; Caballero Correa M; Martínez Jiménez P;
Gastroenterol Hepatol; 2010 Feb; 33(2):80-91. PubMed ID: 19931944
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection].
MMW Fortschr Med; 2004 May; 146(22):48. PubMed ID: 15373113
[No Abstract] [Full Text] [Related]
11. [Prevention of NSAID induced gastroduodenal ulcers].
Hansen JM; Bytzer P
Ugeskr Laeger; 2001 Oct; 163(44):6103-5. PubMed ID: 11715151
[TBL] [Abstract][Full Text] [Related]
12. Misoprostol and NSAID ulcers.
Isaacs P
Am J Gastroenterol; 1996 Feb; 91(2):187-8. PubMed ID: 8607480
[No Abstract] [Full Text] [Related]
13. The management of upper gastrointestinal problems in patients taking NSAIDs.
Prichard P
Aust Fam Physician; 1991 Dec; 20(12):1739-41. PubMed ID: 1687198
[TBL] [Abstract][Full Text] [Related]
14. Prevention of nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury. A meta-analysis of randomized controlled clinical trials.
Koch M; Dezi A; Ferrario F; Capurso I
Arch Intern Med; 1996 Nov; 156(20):2321-32. PubMed ID: 8911239
[TBL] [Abstract][Full Text] [Related]
15. Use of nonsteroidal anti-inflammatory drugs and gastroprotective agents before the advent of cyclooxygenase-2-selective inhibitors: analysis of a large United States claims database.
Schnitzer TJ; Kong SX; Mavros PP; Straus WL; Watson DJ
Clin Ther; 2001 Dec; 23(12):1984-98. PubMed ID: 11813933
[TBL] [Abstract][Full Text] [Related]
16. Prevention of NSAID-gastropathy.
Ardizzone S; Bianchi Porro G
Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
[TBL] [Abstract][Full Text] [Related]
17. Mitigating GI risks associated with the use of NSAIDs.
Momeni M; Katz JD
Pain Med; 2013 Dec; 14 Suppl 1():S18-22. PubMed ID: 24373106
[TBL] [Abstract][Full Text] [Related]
18. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
Goldstein JL; Huang B; Amer F; Christopoulos NG
Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
[TBL] [Abstract][Full Text] [Related]
19. Trends and determinants of adequate gastroprotection in patients chronically using NSAIDs.
Helsper CW; Smeets HM; Numans ME; Knol MJ; Hoes AW; de Wit NJ
Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):800-6. PubMed ID: 19572313
[TBL] [Abstract][Full Text] [Related]
20. Nonsteroidal anti-inflammatory drugs.
Tseng CC; Wolfe MM
Med Clin North Am; 2000 Sep; 84(5):1329-44. PubMed ID: 11026931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
